Skip to content

MAP Pharmaceuticals, Inc.

-->-->-->-->

Investor Relations

Analyst Coverage

Firm Analyst
Deutsche Bank   David M. Steinberg
Bank of America/Merrill Lynch   Gregg Gilbert
Ladenberg Thalmann   Matt Kaplan
Lazard Capital Markets   William Tanner, Ph.D
Leerink Swann   Joseph P. Schwartz
Wedbush Pac Grow Life Sciences   Liana Moussatos, Ph.D.

MAP Pharmaceuticals, Inc. is followed by the analyst(s) listed above. Please note that any opinions, estimates or forecasts regarding MAP Pharmaceuticals, Inc.'s performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of MAP Pharmaceuticals, Inc. or its management. MAP Pharmaceuticals, Inc. does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.

Stock Information
NASDAQ:MAPP
$15.50  
+ 0.63
Mar 9, 2010 4:00 PM ET
Quotes delayed at least 20 minutes.
Information provided by eSignal.